Pilot & Feasibility Program

飞行员

基本信息

批准号：
10608971
负责人：
ATUL K BHAN
金额：
$ 23.54万
依托单位：
MASSACHUSETTS GENERAL HOSPITAL
依托单位国家：
美国
项目类别：
财政年份：
1997
资助国家：
美国
起止时间：
1997-01-01 至 2026-03-31
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10608971
关键词：
Achievement Appointment Area Award Biology Cells Charge Chemicals Classification Clinical Research Collaborations Development Digestive System Disorders Disease Educational workshop Eligibility Determination Faculty Fostering Funding Funding Agency General Hospitals Goals Grant Growth Health Human Genetics Inflammatory Bowel Diseases Investigation Israel Journals Laboratory Research Letters Massachusetts Medical center Mission Natural Immunity Patients Peer Review Physiological Pilot Projects Postdoctoral Fellow Public Health Schools Publishing Reporting Research Research Personnel Resources Science Scientist Systems Biology Therapeutic Translational Research United States National Institutes of Health Universities adaptive immunity base clinical translation gut microbiome high risk innovation medical schools meetings member novel programs recruit success

项目摘要

PILOT AND FEASIBILITY PROGRAM: PROJECT SUMMARY Dr. Atul Bhan, Pilot and Feasibility Program Director, will evaluate letters of intent for suitability, assist the Center Director with identification of appropriate reviewers, and examine reviews received. Dr. Bhan is charged specifically with reviewing these initial funding proposals in the context of the overall programmatic goals of the Center in fostering new digestive disease investigators and advancing understanding of IBD. He will also chair the meeting of the CSIBD Executive Steering Committee that decides the ranking of proposals for funding. Dr. Kate Jeffrey will serve as the Associate Director of the Pilot and Feasibility Program. The overall goal of the CSIBD Pilot and Feasibility Program is to provide initial support for laboratory, translational, and clinical research relevant to IBD and to stimulate innovative research relevant to IBD. These goals unfold along the P and F Program’s specific aims: 1) Recruit new investigators into digestive disease research by providing funding for IBD-related nascent research programs; and 2) Generate new ideas related to IBD research by providing funding for innovative high-risk high-payoff lines of investigation. All CSIBD members are eligible to receive funding through the Pilot and Feasibility program. In addition, other investigators within MGH, Beth Israel Deaconess Medical Center, Broad Institute, Harvard Medical School, MIT, Tufts, the University of Massachusetts Medical School, and the Harvard School of Public Health may apply for support through this program. Awardees are expected to attend CSIBD seminars and workshops, interact with other Center investigators, and present their findings to the CSIBD members, in addition to formal reporting to the Executive Steering Committee. Over the past 10 years, 71% of Pilot and Feasibility Program awards have been for young investigators without current or past independent NIH support (Type N proposals), 21% have been for Type EN, and 8% have been for Type E. This ongoing priority in funding is reflected in the representative projects funded in the last four years which are included with this renewal application.

飞行员和可行性计划：项目摘要飞行员兼可行性计划总监Atul Bhan博士将评估意向书以适合，请协助中心主任确定适当的审阅者，并检查收到的审核。 Bhan博士被指控特别是在审查这些初始资金建议的情况下，集中在培养新的消化疾病研究者并促进对IBD的了解。他也会主席 CSIBD执行指导委员会的会议决定了资金提案的排名。博士凯特·杰弗里（Kate Jeffrey）将担任飞行员和可行性计划的副主任。 CSIBD飞行员和可行性计划的总体目标是为实验室提供初始支持，转化和临床研究与IBD相关，并刺激与IBD相关的创新研究。这些沿P和F计划的具体目的展开的目标：1）招募新的研究人员参与消化系统疾病通过为IBD相关的新生研究计划提供资金来进行研究； 2）产生与新想法有关为IBD研究提供了创新高风险高付费投资线的资金。所有CSIBD成员都有资格通过飞行员和可行性计划获得资金。另外，其他 MGH的调查人员，贝丝以色列女执事医学中心，布罗德研究所，哈佛医学院，麻省理工学院，塔夫茨，马萨诸塞大学医学院和哈佛公共卫生学院通过此程序申请支持。预计获奖者将参加CSIBD的SEMIAR和研讨会，与其他中心调查人员互动，并向CSIBD成员提出他们的发现向执行指导委员会报告。在过去的10年中，飞行员的71％和可行性计划奖项是为年轻的调查人员提供的，没有当前或过去的独立NIH支持（n型提案），21％用于EN类型，而8％的人用于类型。资金反映在过去四年中资助的代表项目中更新申请。